The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.
Eli Lilly and Novo Nordisk, which dominate the market with their obesity injections Zepbound and Wegovy, are both looking to develop next-generation versions. A weight loss pill would offer ...
Ozempic has been approved for diabetes, though it's sometimes still used for weight loss. Rybelsus is a similar drug that's the same price and uses the same ingredient as Ozempic. But Rybelsus is ...
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...
From science-backed supplements to insurance-covered nutrition therapy, here's your complete guide to effective weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback